U.S. flag An official website of the United States government
  1. Home
  2. About FDA
  3. FDA Organization
  4. Oncology Center of Excellence
  5. OCE Meetings and Workshops
  1. Oncology Center of Excellence

OCE Meetings and Workshops

Image
Colorful calendar 2024-2027

Upcoming Oncology Meetings and Events

 

 

2020

  • November 19, 2020: Conversations on Cancer: Lung Cancer: It Can Happen to Anyone. Meeting Information
  • July 17, 2020: FDA-ASCO Public Workshop: 2020 Clinical Outcome Assessments in Cancer Clinical Trials. Meeting Information and recordings 
  • May 19, 2020: Conversations on Cancer: OCE Salutes the Mosaic of Oncology Nursing. 
  • February 28, 2020: FDA-AACR-IASLC Workshop to Address the Criticality of Tobacco Use Assessment in Oncology Treatment Trials. Meeting Information
  • February 20, 2020: Community Engagement with the Community in Mind, Chicago, IL. #OCEProjectCommunity
  • February 13, 2020: FDA-AACR Workshop to Examine Under-representation of African Americans in Multiple Myeloma Clinical Trials. Meeting Information
  • February 5, 2020: FDA Oncology Center of Excellence: Envisioning Oncology Product Development for 2025: Meeting information

2019

  • October 8, 2019: FDA Public Workshop: Partners in Progress 2019–Cancer Patient Advocates and FDA. Meeting Information
  • August 8, 2019: FDA-BCAN Workshop: Endpoints for the Development of Neoadjuvant Systemic Therapy Regimens for Muscle-Invasive Bladder Cancer. Meeting Information
  • July 19, 2019: FDA-AACR Regulatory Science and Policy Workshop: Real-World Evidence. Meeting Information
  • July 12, 2019: FDA-ASCO Public Workshop: 2019 Clinical Outcome Assessments in Cancer Clinical Trials. Meeting Information
  • May 31, 2019: FDA-ASCO Fellows Day Public Workshop: Meeting Information
  • May 16, 2019: FDA-Reagan-Udall Foundation Public Workshop: Project Facilitate & EA Navigator: Working Together to Enable Patient Access to Investigational Oncology Drugs. Meeting Information
  • May 8-10, 2019: FDA-Duke Public Workshop: Accelerating Anticancer Agent Development and Validation. Meeting Information
  • April 26, 2019: FDA-ASCO-FOCR Workshop on Development of Tissue-Agnostic, Biomarker-Based Indications. Meeting Information
  • April 17, 2019: FDA-PDS Symposium. Meeting Information
  • March 22, 2019: FDA-NBTS Public Workshop: Product Development for Central Nervous System Metastases. Meeting Information
  • March 15, 2019: FDA Public Workshop: Childhood Cancer Advocacy Forum. Meeting Information
  • March 8, 2019: FDA-ASCO Fellows Day. Meeting Information

  • December 6, 2018: FDA Public Workshop: Product Development in Hemophilia. Meeting Information
  • November 27, 2018: FDA Public Workshop: Partners in Progress 2018 – Cancer Patient Advocates and FDA. Meeting information
  • October 29, 2018: FDA Public Workshop: Clinical Trials to Optimize Outcomes in Early Breast Cancer. Meeting Information
  • October 17-18, 2018: FDA-ASH Public Workshop: Sickle Cell Disease Clinical Endpoints. Meeting Information
  • July 11, 2018: FDA Public Workshop: Development of Treatments for Localized Prostate Cancer Meeting Information
  • June 22, 2018: 2018 Clinical Outcome Assessments in Cancer Clinical Trials Workshop. Meeting Information
  • June 14, 2018: FDA-AACR-SGO Workshop on Drug Development in Gynecologic Malignancies. Meeting Information
  • April 20, 2018: OCE Public Meeting on Relevant Molecular Targets in Pediatric Cancers. Meeting Information
  • March 15, 2018: OCE Listening Session. Meeting Information; Webcast Information; Agenda
  • March 1-2, 2018: IASLC-FDA Lung Cancer Neoadjuvant Meeting 2018. Meeting Information 
  • Feb. 22-23, 2018: FDA-AACR-ASTRO Clinical Development of Drug-Radiotherapy Combinations. Meeting Information 
  • Feb. 1, 2018: FDA-ISoP Public Workshop: Model Informed Drug Development for Oncology Products. Meeting Information 
  • Jan. 29, 2018: Weighing the Evidence—Variant Classification and Interpretation in Precision Oncology. Meeting Information

2017

  • December 1, 2017: Assessment of Cardiovascular Toxicities in Immuno-Oncology Trials. Meeting information
  • November 28, 2017: Defining Disease Recurrence and Harmonizing Conduct in Adjuvant Bladder and Kidney Cancer Trials. Meeting information
  • November 13, 2017: Partners in Progress: Cancer Patient Advocates and FDA. Save the date: Meeting information
  • November 6, 2017: FDA-ASCO Public Workshop: Geriatric Oncology Workshop. Meeting information
  • October 10, 2017: FDA-AACR Liquid Biopsies in Oncology Drug and Device Development Part II. Meeting Information 
  • July 20, 2017: FDA-AACR Oncology Dose Finding Workshop. Meeting information: FDA; AACR 
  • May 3-5, 2017: Accelerating Anticancer Agent Development and Validation Workshop. Meeting information
  • April 25, 2017: FDA/C-Path Consortium Second Annual Workshop on Clinical Outcomes Assessments in Cancer Clinical Trials. Meeting information 
  • Feb 23, 2017: FDA-ASCO: Hematology and Oncology Fellows Day Workshop. Meeting information

Information about events prior to 2017 can be found in the FDA Archive.

 

Back to Top